The absolute risks of developing metastatic prostate cancer or dying from the disease are low among US veterans who have a normal PSA level less ... of prostate cancer death less than 0.73% ...

Dr. Barry W. Goy explains how to interpret PSA levels after prostate cancer treatment and how to manage recurrence based on ...

Among those with intermediate-risk prostate cancer, high PSA levels prior to HIFU led to an increased risk of overall recurrence and treatment failure. Patients with HRR-deficient metastatic ...

An analysis of prostate cancer trends in California revealed an unexpected spike in distant-stage disease cases between 2011 ...

A high omega-3, low omega-6 diet with fish oil led to a significant reduction in a biomarker for prostate cancer progression ...

it is called metastatic prostate cancer. The grade group, Gleason score, and PSA levels can be any number at this point. The metastatic prostate cancer symptoms depend on the tumor size and the ...

Christian Edouard-Betsy was at work when his doctor called and asked him to meet immediately to discuss the results of a blood test for his prostate.

Impact of Funding Source on Long-Term Outcomes in Prostate Cancer ... baseline PSA level. The lowest PSA value during treatment was considered the best response. The patients who had less than two PSA ...

Combination treatment with cabozantinib and atezolizumab did not produce any new safety signals in the treatment of those with metastatic castration-resistant prostate cancer in the phase 3 ...

New Data for NUBEQA® Build on Safety and Efficacy Results Across Subgroups of Patients with Metastatic Hormone-Sensitive Prostate Cancer ...

2. Clarity Pharmaceuticals. Clarity receives U.S. FDA Fast Track Designation for 64Cu-SAR-bisPSMA in biochemical recurrence of prostate cancer. https://www.claritypharmaceuticals.com/news/ftd-2/ ...